SCIENTIFIC BACKGROUND

F13A1

Category:

SCIENTIFIC BACKGROUND

Congenital factor XIII deficiency is an autosomal recessive inherited coagulation disorder caused by a decreased amount of factor XIII (FXIII). This rare coagulation disorder affects both sexes equally. The estimated prevalence of FXIII deficiency is approximately 1:2.5 million. Symptoms can occur at any age, but the diagnosis is often made in infancy due to umbilical cord stump bleeding. Other symptoms include delayed wound healing, postoperative bleeding, subcutaneous or tissue hemorrhage, life-threatening cerebral hemorrhage, and repeated spontaneous abortions in women.

 

Factor XIII is a transglutaminase consisting of two catalytic A subunits and two non-catalytic B subunits. Activated factor XIII (aFXIII) is necessary for cross-linking and stabilization of fibrin, and it plays an important role in blood clotting through its hemostatic and reparative functions. In most cases, mutations in the gene encoding the A subunit (F13A1 gene) are causative for FXIII deficiency. In rare cases, mutations in the gene encoding the B subunit (F13B gene) have been observed. A severe bleeding tendency is found in homozygous or combined heterozygous carriers of pathogenic variants, and factor XIII activity is often less than 5% in these cases. Heterozygous carriers do not usually show an increased bleeding tendency and have a reduced FXIII activity of 30-60%. In most cases, the bleeding tendency correlates with the measured factor XIII activity.

 

Factor XIII deficiency is difficult to diagnose biochemically because it cannot be detected by the screening coagulation parameters prothrombin time, partial thromboplastin time, and thrombin time. These tests show inconspicuous values despite a massive bleeding tendency. Therefore, a factor XIII functionality test is recommended as a first-line screening test for the diagnosis of factor XIII deficiency. Molecular genetic testing can confirm the diagnosis.

 

Factor XIII deficiency can also be acquired. Causes include liver synthesis disorders, inflammatory bowel disease, consumption coagulopathy, or factor XIII inhibition (e.g., caused by medication).

 

Substitution therapy with factor XIII concentrates is possible.

 

References

Tahlan et Ahluwalia 2014, Arch Pathol Lab Med 138:278 / Bolton-Maggs 2013, Pediatr Blood Cancer 60:37 / Levy et Greenberg 2013, Transfusion 53:1120 / Eshghi et al. 2012, IJBC 2:85 / Biswas et al. 2011, Blood Reviews 25:193 / Kohler et al. 2011, J Thromb Haemost 9:1404 / Wells et al. 2006, Am J Epidemiol 164:101

GENES

F13A1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more